|
Amoxibactin vet
|
50 mg
|
V/DCP/14/0059
|
Le Vet Beheer B.V., Nīderlande
|
QJ01CA04
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 220216LI (28-Apr-2020)
|
| Labelling text: |
[DOCX] 220216M (28-Apr-2020)
|
| Summary of product characteristics: |
[DOCX] 220216ZA (28-Apr-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0059-01 |
50 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-02 |
50 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-03 |
50 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-04 |
50 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-05 |
50 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-06 |
50 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-07 |
50 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-08 |
50 mg |
8 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-09 |
50 mg |
9 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-10 |
50 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-11 |
50 mg |
25 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-12 |
50 mg |
50 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0059-13 |
50 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Amoxibactin vet
|
250 mg
|
V/DCP/14/0060
|
Le Vet Beheer B.V., Nīderlande
|
QJ01CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 220216LI (28-Apr-2020)
|
| Labelling text: |
[DOCX] 220216M (28-Apr-2020)
|
| Summary of product characteristics: |
[DOCX] 220216ZA (28-Apr-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0060-01 |
250 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-02 |
250 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-03 |
250 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-04 |
250 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-05 |
250 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-06 |
250 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-07 |
250 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-08 |
250 mg |
8 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-09 |
250 mg |
9 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-10 |
250 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-11 |
250 mg |
25 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-12 |
250 mg |
50 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0060-13 |
250 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Amoxibactin vet
|
500 mg
|
V/DCP/14/0061
|
Le Vet Beheer B.V., Nīderlande
|
QJ01CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Apr-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 220216LI (28-Apr-2020)
|
| Labelling text: |
[DOCX] 220216M (28-Apr-2020)
|
| Summary of product characteristics: |
[DOCX] 220216ZA (28-Apr-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0061-01 |
500 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-02 |
500 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-03 |
500 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-04 |
500 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-05 |
500 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-06 |
500 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-07 |
500 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-08 |
500 mg |
8 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-09 |
500 mg |
9 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-10 |
500 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-11 |
500 mg |
25 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-12 |
500 mg |
50 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/14/0061-13 |
500 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|